Stocks CON Financial statements
Financial statementsConcentra Group Holdings Parent, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Concentra Group Holdings Parent, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Revenue | 1,724 | 1,838 | 1,900 | 2,163 |
| Cost of revenue | 1,242 | 1,326 | 1,372 | 1,550 |
| Gross profit | 482 | 512 | 528 | 613 |
| General and administrative | 150 | 152 | 156 | 203 |
| Operating income | 259 | 288 | 305 | 334 |
| Interest expense | 0.85 | 0.22 | 47.7 | 109 |
| Pre-tax income | 225 | 243 | 231 | 224 |
| Income tax | 52.7 | 57.9 | 59.5 | 51 |
| Net income to minority interests | 5.52 | 4.8 | 5.35 | 6.43 |
| Net income | 167 | 180 | 167 | 166 |
| EBITDA | 332 | 361 | 372 | 410 |
| EPS, basic | 1.60 | 1.73 | 1.46 | 1.30 |
| EPS, diluted | 1.60 | 1.73 | 1.46 | 1.30 |
| Shares, basic (weighted) | 104 | 104 | 114 | 127 |
| Shares, diluted (weighted) | 104 | 104 | 114 | 128 |
| Dividend per share | 0.06 | 0.25 |
Balance sheet
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Cash and equivalents | 37.7 | 31.4 | 183 | 79.9 |
| Receivables | 216 | 218 | 258 | |
| Other current assets | 38.9 | 34.7 | 42.9 | |
| Total current assets | 294 | 437 | 383 | |
| Property, plant and equipment | 178 | 198 | 225 | |
| Lease right-of-use assets | 398 | 436 | 484 | |
| Goodwill | 1,226 | 1,230 | 1,235 | 1,479 |
| Intangible assets | 225 | 205 | 243 | |
| Other non-current assets | 8.41 | 6.59 | 20.5 | |
| Total assets | 2,297 | 2,334 | 2,521 | 2,858 |
| Accounts payable | 20.4 | 19.8 | 21 | |
| Short-term debt | 1.46 | 10.1 | 10.7 | |
| Total current liabilities | 275 | 307 | 337 | |
| Long-term debt | 3.29 | 1,469 | 1,564 | |
| Lease liabilities | 357 | 397 | 444 | |
| Other non-current liabilities | 27.5 | 24 | 44.5 | |
| Total liabilities | 1,156 | 2,222 | 2,438 | |
| Total debt | 4.75 | 1,479 | 1,574 | |
| Paid-in capital | 0 | 261 | 249 | |
| Retained earnings | 685 | 13.6 | 146 | |
| Other comprehensive income | 0 | -3.35 | ||
| Shareholders' equity | 276 | 393 | ||
| Minority interests | 5.37 | 5.04 | 7.74 | |
| Total equity | 979 | 1,161 | 281 | 401 |
| Total liabilities and equity | 2,334 | 2,521 | 2,858 | |
| Shares outstanding | 128 | 129 |
Cash flow statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Net income | 172 | 185 | 172 | 173 |
| Depreciation and amortization | 73.7 | 73.1 | 67.2 | 75.8 |
| Stock-based compensation | 2.14 | 0.65 | 2.33 | 10.5 |
| Deferred income tax | -8.64 | -6.29 | -4.32 | 7.96 |
| Change in receivables | -5.93 | -10.3 | -1.6 | -11.1 |
| Change in payables | 33.8 | 9.57 | 24.6 | 18 |
| Cash from operations | 274 | 234 | 275 | 279 |
| Capital expenditures | -46 | -65 | -64.3 | -82.3 |
| Acquisitions | -9.7 | -6 | -6.97 | -333 |
| Cash from investing | -57.8 | -75.3 | -71.3 | -415 |
| Stock issued | 3.34 | 3.34 | 0 | 0 |
| Share buybacks | 0 | 0 | -15.4 | -22.4 |
| Dividends paid | 0 | 0 | -7.96 | -32.1 |
| Cash from financing | -210 | -165 | -51.5 | 32.1 |
| Net change in cash | 6.73 | -6.28 | 152 | -103 |
| Free cash flow | 228 | 169 | 210 | 197 |
| Interest paid | 31.1 | 44.3 | 49.7 | 109 |
| Income taxes paid | 42.2 | 60.6 | 55.8 | 45.9 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 29.3% | Gross profit / revenue. |
| Operating margin | 16.4% | Operating income / revenue. |
| EBITDA margin | 19.9% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 11.7% | Pre-tax income / revenue. |
| Net margin | 8.7% | Net income / revenue. |
| FCF margin | 11.7% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 14.7% | Cash from operations / revenue. |
| Effective tax rate | 23.1% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 41.7% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 6.6% | Net income / average total assets. |
| Return on invested capital (ROIC) | 15.2% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| Stock-based pay / revenue | 0.6% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 3.0% | Capital expenditures / revenue. |
| D&A / revenue | 3.5% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 13.9% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 7.9% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 16.1% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 8.4% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | 9.6% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 8.9% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 10.2% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 7.2% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | -0.1% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -0.1% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | -11.0% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -6.7% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 1.7% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 0.6% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -6.3% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -4.8% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Dividend per share growth, 1y | 300.0% | Dividend per share vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | 42.7% | Book value vs the same period a year earlier. Only from a positive base. |
| Total assets growth, 1y | 13.4% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 7.6% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | 12.3% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 7.3% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.38x | Current assets / current liabilities. |
| Quick ratio | 1.24x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.43x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 3.30x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 52.3% | Total debt / total assets. |
| Liabilities / assets | 83.2% | Total liabilities / total assets. |
| Net debt | $1.42B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 3.11x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Working capital | $138.5M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 49.2% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$1.00B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.76x | Revenue / average total assets. |
| Fixed asset turnover | 10.1x | Revenue / average property, plant and equipment. |
| Receivables turnover | 7.63x | Revenue / average receivables. |
| Days sales outstanding | 48 days | 365 x average receivables / revenue. |
| Days payables | 8 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | 134.6% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 20.3% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $1.56 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $17.90 | Revenue / diluted weighted shares. |
| FCF per share | $2.09 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $2.63 | Cash from operations / diluted weighted shares. |
| Book value per share | $3.74 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$7.87 | Tangible book value / shares outstanding. |
| Cash per share | $1.24 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 16.1% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 12.0% | Dividends paid / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $4.46B | Share price x shares outstanding. |
| Enterprise value | $5.88B | Market cap + total debt - cash - short-term investments. |
| P/E | 22.5x | Market cap / net income. Only when net income is positive. |
| P/S | 1.95x | Market cap / revenue. |
| P/B | 9.36x | Market cap / shareholders' equity. Only when equity is positive. |
| P/FCF | 16.7x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 13.3x | Market cap / cash from operations, when positive. |
| EV/Sales | 2.57x | Enterprise value / revenue. |
| EV/EBIT | 15.7x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 12.9x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 22.0x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 6.0% | Free cash flow / market cap. |
| Earnings yield | 4.5% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 0.7% | Dividends paid over the period / market cap. |
| Shareholder yield | 0.7% | (Dividends paid + share buybacks) / market cap. |
What was Concentra Group Holdings Parent, Inc.'s revenue in fiscal 2025?
Concentra Group Holdings Parent, Inc. reported revenue of $2.16B for fiscal 2025, 13.9% higher than the year before.
Was Concentra Group Holdings Parent, Inc. profitable in fiscal 2025?
Yes. Net income was $166.4M, a net margin of 7.7%.
How much free cash flow did Concentra Group Holdings Parent, Inc. generate in fiscal 2025?
Cash from operations of $279.4M minus capital expenditures of $82.3M left free cash flow of $197.1M.